Infectious Disease Diagnostic Market Outlook 2031
The global infectious disease diagnostic market size was USD 26.60 Billion in 2022 and is anticipated to reach USD 48.09 Billion by 2031 register a substantial CAGR 5.8% during the forecast period, 2023–2031. The growth of the market is attributed to the growing prevalence of various infectious diseases across the globe. Infectious diseases include malaria, TB, HIV/AIDS, hepatitis, HAIs, STDs, diarrheal diseases, among others.
The prevalence of infectious diseases leads to increasing morbidity and mortality across the globe. Diagnosis is the initial step of discovering a disease and its treatment leads to elimination of infectious diseases. The outbreak of COVID-19 pandemic has affected the global infectious disease diagnostic market in several ways. The outbreak resulted in major shortage of diagnostic kits to test for the Sars-Cov-2 infection. On the other hand, diagnostic virology entities are under immense pressure to develop reliable testing kits.
There is a substantial need to identify suitable diagnostic technique owing to the evolving pathogens and emergence of new diseases. These diagnostic techniques help the physicians to decide the appropriate treatment for the disease. There is a significant change in the performance of rapid diagnostics tests owing to the continuous research and development activities in techniques such as mass spectrometry and next-generation sequencing (NGS).
The point-of-care diagnostics offer various actionable data for patients care and treatment. There is a significant shift in focus from centralized laboratories to decentralized point-of-care testing along with increase in funding for research on infectious diseases.
Infectious Disease Diagnostic Market Drivers, Restraints, Trends, and Opportunities
- Growing inclination of end-user towards point-of-care testing is projected to spur the market growth during the forecast period.
- Prevalence of infectious diseases such as HPV, hepatitis, HIV and tuberculosis are increasing across the globe, thereby driving the infectious disease diagnostic market growth.
- Increasing demand for rapid diagnostic techniques as compared to the current techniques owing to the long result time and supportive government funding is expected to drive the market growth.
- Budgetary consideration between the healthcare systems is a key challenge for implementing the novel diagnostic techniques in clinical laboratories owing to low reimbursements for these tests.
- Reduction in reimbursements policies is projected to negatively impact the adoption of molecular and genetic testing, which is further expected to hamper the market growth.
- Growing preference of consumers towards the benefits of personalized medicine is projected to boost the use of molecular diagnostic and genomics & proteomics technologies.
- Availability of genetic & molecular tests enables the early detection of diseases and provides personalized treatment. This is expected to ensure substantial savings in treatment costs.
- Increasing demand for clinical microbiology services business have boosted the business growth in the recent years.
Scope of Infectious Disease Diagnostic Market Report
The report on the global infectious disease diagnostic market includes an assessment of the market, trends, segments, and regional markets. Overview and dynamics have also been included in the report.
|
Attributes
|
Details
|
|
Report Title
|
Infectious Disease Diagnostic Market - Global Industry Analysis, Growth, Share, Size, Trends, and Forecast
|
|
Base Year
|
2022
|
|
Historic Data
|
2016–2021
|
|
Forecast Period
|
2023–2031
|
|
Segmentation
|
Products (Consumables [Assays and Reagents], Software & Services, and Instruments & Analysers), Technology (Molecular Diagnostic Techniques, and Traditional Diagnostic Techniques), and Applications (Hepatitis C, Hepatitis B, Tuberculosis (TB), Acquired Immunodeficiency Syndrome (AIDS), Human Papillomavirus (HPV), and Methicillin-resistant Staphylococcus Aureus (MRSA))
|
|
Regional Scope
|
North America, Europe, Asia Pacific, Latin America, and Middle East & Africa.
|
|
Report Coverage
|
Company Share, Market Analysis and Size, Competitive Landscape, Growth Factors, and Trends, and Revenue Forecast
|
|
Key Players Covered in the Report
|
Bio Mérieux SA, Roche Diagnostics, Abbott Laboratories, Thermo Fischer Scientific, Inc., Becton, Dickinson & Company, Bio-Rad Laboratories. Alere Inc, Danaher Corporation, and Johnson and Johnson.
|
Global Infectious Disease Diagnostic Market Segment Insights
Consumables segment is projected to represent a considerable market share
On the basis of products, the market is categorized into consumables, software & services, and instruments & analyzers. The consumables segment is further divided into assays and reagent. The consumables segment is projected to represent a considerable market share during the forecast period. The availability of a diverse range of assays & reagents for diagnosis of various disease and their expense.
Additionally, the outbreak COVID-19 is projected to fuel the market growth as there is a huge requirement of various kits and assays. Roche, bioMerieux and Bio-Rad are some of the key industry participants for assays, kits & reagents in the infectious disease diagnostics market.
Molecular diagnostic techniques segment to constitute a large market share
In terms of technology, the market is bifurcated into molecular diagnostic techniques and traditional diagnostic techniques. The molecular diagnostic techniques segment is anticipated to constitute a large market share during the forecast period. The molecular diagnostic technique segment is further categorized into INAAT (Isothermal Nucleic Acid Amplification Test), Polymerase Chain Reaction (PCR), NGS & DNA sequencing, hybridization, and microarrays.
The growth in sequencing technology, rise in awareness of personalized medicine and increasing application in pharmacogenetics and point-of-care testing is projected to fuel the segment growth during the forecast period.
Recently, NGS sequencing segment has gained significant traction in drug discovery and pharmacogenetics. There is a considerable change in the development, testing and targeting of new medicines. Recent technological advancements and reducing prices of NGS based tests is anticipated to further propel the segment growth.
Furthermore, the PCR and INAAT based tests hold a considerable market share. The PCR is a reaction process that generates multiple images of DNA from a particular DNA sequence. The traditional diagnostic technique segment is expected to expand at a healthy CAGR during the forecast period. The segment is further classified into biochemical characterization, microscopy, and immunodiagnostics.
Tuberculosis (TB) segment is expected to account for a significant market share
Based on applications, the market is categorized into Hepatitis C, Hepatitis B, Tuberculosis (TB), Acquired Immunodeficiency Syndrome (AIDS), Human Papillomavirus (HPV), and Methicillin-resistant Staphylococcus Aureus (MRSA). The TB segment is expected to account for a significant market share during the forecast period. TB usually occurs due to mycobacterium tuberculosis. The growing number of TB cases across the globe is driving the segment growth.
North America region is anticipated to represent a large market share.
In terms of regions, the market is classified as North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. North America is anticipated to represent a large market share during the forecast period. The presence of a large number of the patient population in this region is propelling the regional growth of the infectious disease diagnostic market.
Additionally, growing investment in the healthcare infrastructure, and several government initiatives is projected to further boost the market growth in this region. On the other, the market in Asia Pacific is estimated to expand at a high CAGR during the forecast period. The increasing prevalence of infectious diseases, and rise in patient awareness is driving the market in the Asia Pacific region.
Segments
The global infectious disease diagnostic market has been segmented on the basis of
Products
- Consumables
- Software & Services
- Instruments & Analyzers
Technology
- Molecular Diagnostic Techniques
- Traditional Diagnostic Techniques
Applications
- Hepatitis C
- Hepatitis B
- Tuberculosis (TB)
- Acquired Immunodeficiency Syndrome (AIDS)
- Human Papillomavirus (HPV)
- Methicillin-resistant Staphylococcus Aureus (MRSA)
Regions
- Asia Pacific
- North America
- Latin America
- Europe
- Middle East & Africa
Key players
Competitive Landscape
Some of the key players in the global infectious disease diagnostic market include Bio Mérieux SA, Roche Diagnostics, Abbott Laboratories, Thermo Fischer Scientific, Inc., Becton, Dickinson & Company, Bio-Rad Laboratories. Alere Inc, Danaher Corporation and Johnson and Johnson. The industry participants are providing their focus on research and development activities to generate point-of-care diagnostics solutions for emerging economies.
Request For Customization
Enquiry Before Buying
Speak With Analyst
